Business
Bionik Laboratories Announces Closing of Acquisition of Interactive Motion Technologies, Inc. (IMT)
Bionik Laboratories Announces Closing of Acquisition of Interactive Motion Technologies, Inc. (IMT).
About this update from Bionik Laboratories Corp.
[{"type":"text","content":"\n\n\n\nBionik Laboratories Announces Closing of Acquisition of Interactive Motion Technologies, Inc. (IMT)\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n\n\n\n\n\n\nBionik Laboratories Announces Closing of Acquisition of Interactive Motion Technologies, Inc. (IMT)\n- Bionik now provides a wider range of rehabilitation solutions for individuals with neurological disorders living with both upper and lower body mobility challenges\n- Transaction further differentiates Bionik in the robotics market\n- Preeminent leaders in robotics technology development join Bionik team effective immediately\n- Bionik to focus on executing near-term strategy to accelerate market expansion and revenue generation with product integration\nPR Newswire\nTORONTO, April 21, 2016\n\n\n\nTORONTO, April 21, 2016 /PRNewswire/ -- Bionik Laboratories Corp. (OTCQX: BNKL), a global pioneering robotics company focused on providing rehabilitation solutions to individuals with neurological disorders (\"Bionik\" or the \"Company\"), announced today it has acquired all of the outstanding shares and, accordingly, all assets and liabilities of Interactive Motion Technologies, Inc. (\"IMT\"), a Boston, Massachusetts-based global pioneer and leader in providing effective robotic tools for neurorehabilitation. \n\n\nEffective immediately, Jules Fried, IMT's Chief Executive Officer, has been appointed to Bionik's management team as VP, U.S. Operations and Hermano I. Krebs, Ph.D., M.S., IMT's Co-Founder and Chairman of the Board, has been appointed Chief Science Officer of the Company. Dr. Neville Hogan, Sun Jae Professor of Mechanical Engineering and Professor of Brain and Cognitive Sciences at the Massachusetts Institute of Technology (\"MIT\"), a member of IMT's Board of Directors, has assumed an advisory role to the Bionik team. Drs. Krebs and Hogan are the co-founders of IMT, researchers at MIT and world leaders in robot-aided rehabilitation. Bionik will maintain IMT's U.S. office based in Boston, Massachusetts.  \n\n\"The closing of this transaction marks a significant milestone in the evolution of ...